Conventus Orthopaedics, Inc. announced today that it signed adefinitive agreement to acquire Flower Orthopedics. The acquisition will close following completion of all closingconditions. Terms were not disclosed.
Flower Orthopedics, is a market leader in sterile-packaged anatomic foot & ankle implants, allografts and diabetic wound care solutions for orthopedic surgeons and podiatrists. Conventus was first recognized for its platform proprietary nitinol CAGE technology to treat proximal humerusand distal radius fractures with unmatched stability and reduced complications compared to plating. Lower extremity CAGE implants are in development. The Flower Ortho acquisition follows Conventus’ recent acquisition of an innovative intramedullary distal fibulasystem from Surgical Frontiers.
Rick Epstein, Conventus CEO, stated, “Flower is an excellent strategic fit with Conventus. With the backing of our lead investor, Deerfield Management, Flower represents the next step of our aggressive transformation into a formidable orthopedic supplier. We will continue to expand our distribution channel and enhance our portfolio through product development and acquisitions that address unmet sur...
